Airsculpt Technologies, Inc.(AIRS)Stock Analysis

AIRS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Airsculpt Technologies, Inc. (AIRS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AIRS at 24.3/100 on a 32-signal composite quality model, placing it at rank #2,587 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (4.1) and revenue growth (12.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Airsculpt Technologies, Inc. reports quarterly revenue of $39.4M, net income of $-2.4M, an operating margin of -4.6%. Top institutional holders of AIRS by reported 13-F value include Vesey Street Capital Partners, L.L.C., BALYASNY ASSET MANAGEMENT L.P., FourWorld Capital Management, based on the most recent SEC filings. AIRS trades on the Nasdaq exchange and files with the SEC under CIK 1870940. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AIRS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Airsculpt Technologies, Inc. directly from SEC EDGAR.